Showing 381-390 of 2822 results for "".
Neuroimmunomodulation & COVID-19
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neuroimmunomodulation-covid-19/31743/Use of immunotherapies for neurologic conditions in the COVID-19 era is a double-edged sword.Pediatric Neuromuscular Disorders Encountered in the Adult Neurology Clinic
https://practicalneurology.com/diseases-diagnoses/neuromuscular/pediatric-neuromuscular-disorders-encountered-in-the-adult-neurology-clinic/39965/Genetic pediatric neuromuscular disorders are becoming increasingly prevalent in the adult neurology clinic, requiring adult neurologists and neuromuscular providers to be familiar with a group of disorders previously considered outside their scope of practice.Diagnostic & Treatment Delay in Temporal Lobe Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/diagnostic-treatment-delay-in-temporal-lobe-epilepsy/31835/The average 20-year delay of referral to epilepsy centers can be improved.AntiCD20+ Agents
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/anticd20-agents/31630/AntiCD20+ agents are among the highest efficacy treatments for multiple sclerosis.Neural Antibodies as Diagnostic Biomarkers of Autoimmune Encephalitis and Inflammatory Demyelinating Disease
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neural-antibodies-as-diagnostic-biomarkers-of-autoimmune-encephalitis-and-inflammatory-demyelinating-disease/32103/Neural antibodies are diagnostic biomarkers of autoimmune encephalitis, NMOSD, and MOGAD.Duchenne Muscular Dystrophy
https://practicalneurology.com/diseases-diagnoses/child-neurology/duchenne-muscular-dystrophy/31685/Well-established corticosteroid therapy prolongs life, and potentially curative new treatments are in development.Adult Inflammatory Myopathies: Updates on Classification and Management
https://practicalneurology.com/diseases-diagnoses/neuromuscular/adult-inflammatory-myopathies-updates-on-classification-and-management/32123/The inflammatory myopathies are classified into homogeneous subtypes on the basis of specific autoantibodies, and management strategies continue to evolve rapidly.Treating Early Relapsing Multiple Sclerosis: Induction & Escalation Approaches
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/treating-early-relapsing-multiple-sclerosis-induction-escalation-approaches/31873/Evidence-based clinical trial results are needed to guide this difficult decision-making processKappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/kappa-free-light-chain-index-in-the-diagnosis-of-multiple-sclerosis/54598/Adoption of the kappa free light chain index can enhance diagnostic accuracy and reduce latency in multiple sclerosis diagnosis, complementing MRI and expert assessment in clinical decision-making.MOC and Physician Burnout
https://practicalneurology.com/columns/practice-management/moc-and-physician-burnout/30405/Treating the Cause, Not the Symptoms